MDR-001
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
MindRank AI Ltd · Phase 2 · Status n/r · Enrollment 300
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| 90 mg MDR-001 | n/r | n/r | n/r | n/r | n/r |
| 120 mg MDR-001 | n/r | n/r | n/r | n/r | n/r |
| 150 mg MDR-001 | n/r | n/r | n/r | n/r | n/r |
| 180 mg MDR-001 | n/r | n/r | n/r | n/r | n/r |
| placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.